BioLife Solutions, Inc. (BLFS)
USD 22.45
(0.85%)
USD 22.45
(0.85%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 42.69 Million USD | -2.34% |
| 2022 | 43.71 Million USD | 62.63% |
| 2021 | 26.87 Million USD | 141.0% |
| 2020 | 11.15 Million USD | 723.71% |
| 2019 | 1.35 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | -100.0% |
| 2016 | 2.84 Million USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | -100.0% |
| 2013 | 10.6 Million USD | 0.0% |
| 2012 | 10.6 Million USD | 4.67% |
| 2011 | 10.13 Million USD | 12.14% |
| 2010 | 9.03 Million USD | 14.49% |
| 2009 | 7.89 Million USD | 55.83% |
| 2008 | 5.06 Million USD | 84.11% |
| 2007 | 2.75 Million USD | 1292.57% |
| 2006 | 197.47 Thousand USD | -12.59% |
| 2005 | 225.92 Thousand USD | 0.0% |
| 2004 | - USD | -100.0% |
| 2003 | 705.52 Thousand USD | 104.01% |
| 2002 | 345.82 Thousand USD | 0.0% |
| 2001 | - USD | -100.0% |
| 2000 | 10.85 Thousand USD | -93.99% |
| 1999 | 180.66 Thousand USD | 41.92% |
| 1998 | 127.3 Thousand USD | -28.45% |
| 1997 | 177.91 Thousand USD | 0.0% |
| 1996 | - USD | -100.0% |
| 1995 | 53.73 Thousand USD | 0.0% |
| 1994 | - USD | 0.0% |
| 1993 | - USD | 0.0% |
| 1992 | - USD | 0.0% |
| 1991 | - USD | 0.0% |
| 1990 | - USD | 0.0% |
| 1989 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 35.95 Million USD | -12.22% |
| 2024 Q1 | 40.96 Million USD | -4.05% |
| 2023 Q1 | 43.21 Million USD | -1.13% |
| 2023 Q2 | 44.56 Million USD | 3.12% |
| 2023 FY | 42.69 Million USD | -2.34% |
| 2023 Q4 | 42.69 Million USD | -3.42% |
| 2023 Q3 | 44.2 Million USD | -0.82% |
| 2022 Q1 | 25.98 Million USD | -3.32% |
| 2022 Q3 | 43.83 Million USD | 69.56% |
| 2022 Q2 | 25.85 Million USD | -0.5% |
| 2022 FY | 43.71 Million USD | 62.63% |
| 2022 Q4 | 43.71 Million USD | -0.29% |
| 2021 FY | 26.87 Million USD | 141.0% |
| 2021 Q1 | 13.45 Million USD | 20.63% |
| 2021 Q2 | 29.52 Million USD | 119.44% |
| 2021 Q3 | 28.22 Million USD | -4.4% |
| 2021 Q4 | 26.87 Million USD | -4.77% |
| 2020 FY | 11.15 Million USD | 723.71% |
| 2020 Q3 | 755 Thousand USD | -21.35% |
| 2020 Q1 | 1.15 Million USD | -14.48% |
| 2020 Q2 | 960 Thousand USD | -17.1% |
| 2020 Q4 | 11.15 Million USD | 1377.22% |
| 2019 FY | 1.35 Million USD | 0.0% |
| 2019 Q2 | 1.49 Million USD | -9.83% |
| 2019 Q4 | 1.35 Million USD | -12.31% |
| 2019 Q3 | 1.54 Million USD | 3.28% |
| 2019 Q1 | 1.65 Million USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 FY | - USD | -100.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q2 | - USD | -100.0% |
| 2017 Q1 | 3.93 Million USD | 38.45% |
| 2016 Q1 | - USD | 0.0% |
| 2016 FY | 2.84 Million USD | 0.0% |
| 2016 Q3 | 1.75 Million USD | 166.5% |
| 2016 Q4 | 2.84 Million USD | 62.48% |
| 2016 Q2 | 656.8 Thousand USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2014 Q1 | - USD | -100.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 FY | - USD | -100.0% |
| 2014 Q4 | - USD | 0.0% |
| 2013 Q3 | 10.6 Million USD | 0.0% |
| 2013 Q1 | 10.6 Million USD | 0.0% |
| 2013 FY | 10.6 Million USD | 0.0% |
| 2013 Q4 | 10.6 Million USD | 0.0% |
| 2013 Q2 | 10.6 Million USD | 0.0% |
| 2012 FY | 10.6 Million USD | 4.67% |
| 2012 Q4 | 10.6 Million USD | 0.03% |
| 2012 Q3 | 10.6 Million USD | 0.0% |
| 2012 Q2 | 10.6 Million USD | 2.91% |
| 2012 Q1 | 10.3 Million USD | 1.68% |
| 2011 FY | 10.13 Million USD | 12.14% |
| 2011 Q1 | 9.38 Million USD | 3.84% |
| 2011 Q2 | 9.65 Million USD | 2.88% |
| 2011 Q3 | 9.9 Million USD | 2.62% |
| 2011 Q4 | 10.13 Million USD | 2.29% |
| 2010 Q1 | 8.13 Million USD | 3.14% |
| 2010 FY | 9.03 Million USD | 14.49% |
| 2010 Q3 | 8.73 Million USD | 2.92% |
| 2010 Q4 | 9.03 Million USD | 3.38% |
| 2010 Q2 | 8.49 Million USD | 4.32% |
| 2009 FY | 7.89 Million USD | 55.83% |
| 2009 Q1 | 6.46 Million USD | 27.65% |
| 2009 Q4 | 7.89 Million USD | 3.98% |
| 2009 Q2 | 6.96 Million USD | 7.74% |
| 2009 Q3 | 7.58 Million USD | 8.98% |
| 2008 Q4 | 5.06 Million USD | 13.44% |
| 2008 FY | 5.06 Million USD | 84.11% |
| 2008 Q2 | 3.96 Million USD | 14.44% |
| 2008 Q3 | 4.46 Million USD | 12.62% |
| 2008 Q1 | 3.46 Million USD | 25.93% |
| 2007 Q4 | 2.75 Million USD | 0.0% |
| 2007 Q1 | 750 Thousand USD | 279.79% |
| 2007 Q2 | 1.75 Million USD | 133.33% |
| 2007 Q3 | 2.75 Million USD | 57.14% |
| 2007 FY | 2.75 Million USD | 1292.57% |
| 2006 Q1 | 218.94 Thousand USD | -3.09% |
| 2006 Q4 | 197.47 Thousand USD | -3.54% |
| 2006 Q2 | 211.87 Thousand USD | -3.23% |
| 2006 FY | 197.47 Thousand USD | -12.59% |
| 2006 Q3 | 204.72 Thousand USD | -3.38% |
| 2005 FY | 225.92 Thousand USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | 230.5 Thousand USD | 0.0% |
| 2005 Q4 | 225.92 Thousand USD | -1.98% |
| 2004 Q3 | - USD | 0.0% |
| 2004 FY | - USD | -100.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q1 | - USD | -100.0% |
| 2003 Q3 | 737.72 Thousand USD | 1.64% |
| 2003 Q4 | 705.52 Thousand USD | -4.37% |
| 2003 Q2 | 725.82 Thousand USD | 66.54% |
| 2003 Q1 | 435.82 Thousand USD | 26.02% |
| 2003 FY | 705.52 Thousand USD | 104.01% |
| 2002 Q3 | 369.84 Thousand USD | -26.88% |
| 2002 Q4 | 345.82 Thousand USD | -6.49% |
| 2002 FY | 345.82 Thousand USD | 0.0% |
| 2002 Q1 | 250 Thousand USD | 0.0% |
| 2002 Q2 | 505.82 Thousand USD | 102.33% |
| 2001 Q4 | - USD | -100.0% |
| 2001 FY | - USD | -100.0% |
| 2001 Q3 | 1988.00 USD | -60.62% |
| 2001 Q2 | 5048.00 USD | -36.79% |
| 2001 Q1 | 7986.00 USD | -26.45% |
| 2000 Q2 | 1.05 Million USD | 61.04% |
| 2000 Q4 | 10.85 Thousand USD | -37.42% |
| 2000 FY | 10.85 Thousand USD | -93.99% |
| 2000 Q3 | 17.35 Thousand USD | -98.36% |
| 2000 Q1 | 656.8 Thousand USD | 405.23% |
| 1999 Q3 | 140 Thousand USD | -6.67% |
| 1999 Q1 | 130 Thousand USD | 2.12% |
| 1999 Q4 | 130 Thousand USD | -7.14% |
| 1999 Q2 | 150 Thousand USD | 15.38% |
| 1999 FY | 180.66 Thousand USD | 41.92% |
| 1998 FY | 127.3 Thousand USD | -28.45% |
| 1998 Q1 | 200 Thousand USD | 12.41% |
| 1998 Q2 | 100 Thousand USD | -50.0% |
| 1998 Q3 | 300 Thousand USD | 200.0% |
| 1998 Q4 | 127.3 Thousand USD | -57.57% |
| 1997 Q4 | 177.91 Thousand USD | 196.53% |
| 1997 Q2 | 10 Thousand USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 FY | 177.91 Thousand USD | 0.0% |
| 1997 Q3 | 60 Thousand USD | 500.0% |
| 1996 FY | - USD | -100.0% |
| 1996 Q1 | - USD | 0.0% |
| 1996 Q2 | 22.65 Thousand USD | 0.0% |
| 1996 Q3 | - USD | -100.0% |
| 1995 Q4 | - USD | 0.0% |
| 1995 Q1 | 1 Million USD | 0.0% |
| 1995 FY | 53.73 Thousand USD | 0.0% |
| 1995 Q2 | 53.73 Thousand USD | -94.63% |
| 1995 Q3 | - USD | -100.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1993 Q4 | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 Q1 | - USD | -100.0% |
| 1992 FY | - USD | 0.0% |
| 1992 Q3 | 100 Thousand USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1992 Q4 | 100 Thousand USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 FY | - USD | 0.0% |
| 1989 FY | - USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 85.7 Million USD | 50.189% |
| AngioDynamics, Inc. | 5.91 Million USD | -621.863% |
| AtriCure, Inc. | 74.49 Million USD | 42.692% |
| Avinger, Inc. | 15.39 Million USD | -177.304% |
| Azenta, Inc. | 60.43 Million USD | 29.362% |
| The Cooper Companies, Inc. | 2.56 Billion USD | 98.338% |
| Daxor Corporation | 755.65 Thousand USD | -5549.506% |
| Ekso Bionics Holdings, Inc. | 7.16 Million USD | -495.578% |
| Femasys Inc. | 6.7 Million USD | -537.095% |
| GlucoTrack, Inc. | 196 Thousand USD | -21681.122% |
| Harvard Bioscience, Inc. | 42.77 Million USD | 0.192% |
| Hologic, Inc. | 2.53 Billion USD | 98.316% |
| ICU Medical, Inc. | 1.7 Billion USD | 97.496% |
| Intuitive Surgical, Inc. | 89.8 Million USD | 52.46% |
| KORU Medical Systems, Inc. | 4.44 Million USD | -860.402% |
| LeMaitre Vascular, Inc. | 19.09 Million USD | -123.572% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 970 Million USD | 95.599% |
| Microbot Medical Inc. | 231 Thousand USD | -18380.952% |
| Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | -482.325% |
| Merit Medical Systems, Inc. | 891.35 Million USD | 95.211% |
| Nephros, Inc. | 1.83 Million USD | -2225.218% |
| NovoCure Limited | 596.24 Million USD | 92.84% |
| NEXGEL, Inc. | 2.79 Million USD | -1425.768% |
| NEXGEL, Inc. | 2.79 Million USD | -1425.768% |
| Singular Genomics Systems, Inc. | 75.28 Million USD | 43.296% |
| OraSure Technologies, Inc. | 13.5 Million USD | -216.136% |
| Pro-Dex, Inc. | 13.54 Million USD | -215.133% |
| Pulse Biosciences, Inc. | 9.14 Million USD | -366.874% |
| Predictive Oncology Inc. | 2.85 Million USD | -1394.357% |
| Precision Optics Corporation, Inc. | 3.43 Million USD | -1143.019% |
| QuidelOrtho Corporation | 2.61 Billion USD | 98.367% |
| Repligen Corporation | 711.8 Million USD | 94.002% |
| Sanara MedTech Inc. | 11.79 Million USD | -262.03% |
| STAAR Surgical Company | 35.83 Million USD | -19.135% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 342 Thousand USD | -12382.749% |
| DENTSPLY SIRONA Inc. | 2.29 Billion USD | 98.143% |
| Jin Medical International Ltd. | 4.11 Million USD | -937.953% |